A3 adenosine receptor activation in melanoma cells: Association between receptor fate and tumor growth inhibition

Journal of Biological Chemistry

Volumn 278, Issue 43, 2003, Pages 42121-42130

  Madi, Lea ^a   Bar Yehuda, Sara ^a,b   Barer, Faina ^a   Ardon, Eti ^a   Ochaion, Avivit ^a   Fishman, Pnina ^a,b  

^a Can Fite BioPharma Ltd   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

BIODEGRADATION; GROWTH KINETICS; PROTEINS; TUMORS;

GROWTH INHIBITION;

CELL CULTURE;

1 DEOXY 1 [6 [[(3 IODOPHENYL)METHYL]AMINO] 9H PURIN 9 YL] N METHYL BETA DEXTRO RIBOFURANURONAMIDE; 6 ETHYL 4 PROPYL 2 PHENYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIN D1; FURAN DERIVATIVE; GLYCOGEN SYNTHASE KINASE 3BETA; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; MESSENGER RNA; MYC PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER INHIBITION; CONTROLLED STUDY; CYTOSOL; DOWN REGULATION; ENDOSOME; INTERNALIZATION; LYSOSOME; MALE; MELANOMA CELL; MESSENGER RNA SYNTHESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS; PROTEIN TARGETING; RECEPTOR INTRINSIC ACTIVITY;

ADENOSINE; ANIMALS; CELL DIVISION; CELL LINE, TUMOR; CYCLIN D1; DOWN-REGULATION; MELANOMA; MICE; MICE, INBRED C57BL; NEOPLASM PROTEINS; NEOPLASMS, EXPERIMENTAL; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, ADENOSINE A3; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0142211261     PISSN: 00219258     EISSN: None     Source Type: Journal    
DOI: 10.1074/jbc.M301243200     Document Type: Article

References (28)

1. Fishman, P., Bar-Yehuda, S., Ohana, G., Pathak, S., Wasserman, L., Barer, F., and Multani, A. S. (2001) Exp. Cell Res. 269, 230-236
2. Fishman, P., Madi, L., Bar-Yehuda, S., Barer, F., Del Valle, L., and Khalili, K. (2002) Oncogene 21, 4060-4064
3. Ohana, G., Bar-Yehuda, S., Barer, F., and Fishman, P. (2001) J. Cell. Physiol. 156, 19-23
4. Olah, M. E., and Stiles, G. L. (2000) Pharmacol. Ther. 85, 55-75
5. Poulsen, S. A., and Quinn, R. J. (1998) Bioorg. Med. Chem. 6, 619-641
6. Fang, X., Yu, S. X., Lu, Y., Bast, R. C., Woodgett, J. R., and Mills, G. B. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 11960-11965
7. Robbins, P. F., El-Gamil, M., Li, Y. F., Kawakami, Y., Loftus, D., Appella, E., and Rosenberg, S. A. (1996) J. Exp. Med. 183, 1185-1192
8. Morin, P. J. (1999) BioEssays 21, 1021-1030
9. Bonvini, P., Hwang, S. G., El-Gamil, M., Robbins, P., Kim, J. S., Trepel, J., and Neckers, L. (2000) Biochim. Biophys. Acta 1495, 308-318
10. Schmid, S. L., Fuchs, R., Male, P., and Mellman, I. (1988) Cell 52, 73-83
11. Gessi, S., Varani, K., Merighi, S., Morreli, A., Ferrari, D., Leung, E., Baraldi, P. G., Spalutto, G., and Borea, P. A. (2001) Br. J. Pharmacol. 134, 116-126
12. Merighi, S., Varani, K., Gessi, S., Cattabriga, E., Iannotta, V., Ulouglul, C., Leung, E., and Borea, P. A. (2001) Br. J. Pharmacol. 134, 1215-1226
13. Suh, B. C., Kim, T. D., Lee, J. U., Seong, J. K., and Kim, K. T. (2001) Br. J. Pharmacol. 134, 132-142
14. Montesinos, M. C., Desai, A., Delano, D., Chen, J. F., Fink, J. S., Jacobson, M. A., and Cronstein, B. N. (2003) Arthritis Rheum. 48, 240-247
15. Merimsky, O., Madi, L., Bar-Yehuda, S., and Fishman, P. (2003) Drug Dev. Res. 58, 386-389
16. Fishman, P., and Bar-Yehuda, S. (2003) Curr. Top. Med. Chem. 3, 1349-1364
17. Ceresa, B. P., and Schmid, S. L. (2000) Curr. Opin. Cell Biol. 12, 204-210
18. Petrou, C., Chen, L., and Tashjian, A. H., Jr. (1997) J. Biol. Chem. 272, 2326-2333
19. Trincavelli, M. L., Tuscano, D., Cecchetti, P., Falleni, A., Benzi, L., Klotz, K. N., Gremigni, V., Cattabeni, F., Luccachini, A., and Martini, C. (2000) J. Neurochem., 75, 1493-1501
20. Trincavelli, M. L., Tuscano, D., Marroni, M., Falleni, A., Gremigni, V., Ceruti, S., Abbracchio, M. P., Jacobson, K. A., Cattabeni, F., and Martini, C. (2002) Mol. Pharmacol. 62, 1373-1384
21. Ferguson, G., Watterson, K. R., and Palmer, T. M. (2002) Biochemistry 41, 14748-14761
22. Ferkey, D. M., and Kimelman, D. (2000) Dev. Biol. 225, 471- 479
23. Bunemann, M., Lee, K. B., Pals-Rylaasdam, R., and Hosey, M. (1999) Annu. Rev. Physiol. 61, 169-192
24. Claing, A., Laporte, S. A., Caron, M. G., and Lefkowitz, R. J. (2002) Prog. Neurobiol. 66, 61-79
25. D'agnano, I., Valentini, A., Fornari, C., Bucci, B., Starace, G., Felsani, A., and Citro, G. (2001) Oncogene 20, 2814-2825
26. Parrella, P., Caballero, O. L., Sidranski, D., and Merbs, S. L. (2001) Investig. Ophthalmol. Vis. Sci. 42, 1679-1688
27. Kim, S. G., Ravi, G., Hoffmann, C., Jung, Y. J., Kim, M., Chen, A., and Jacobson, K. A. (2002) Biochem. Pharmacol. 63, 871-880
28. Appel, E., Kazimirsky, G., Ashkenazi, E., Kim, S. G., Jacobson, K. A., and Brodie, C. (2001) J. Mol. Neurosci. 17, 285-292